Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
BrainStorm Cell Therapeutics
4645
BrainStorm Cell Therapeutics
Health Care
Technology
Biotechnology
Medical
Therapeutics
Biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD.
Suggest edits
Founded
2004
Raised
$35.2M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Goldman Sachs
Bloomberg
Kickstarter
Wired
JPMorgan
The New York Times
Tumblr
Companies in the same industry
PDC*line Pharma
Lysosomal Therapeutics
Arcturus Therapeutics
ELSALYS BIOTECH
Quentis Therapeutics
Wilson Therapeutics
Hookipa Pharma
Genomics plc
Immune Design
Alder Biopharmaceuticals Inc. (Nasdaq: ALDR)
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Add round
21 Jul
2017
$16,000,000
Grant
California Institute for Regenerative Medicine
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS
prnewswire
13 Jun
2017
$2,100,000
Grant
Israel Innovation Authority
Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy
Drug Delivery Business
24 Jul
2014
$5,000,000
Grant
13 Jun
2014
$10,500,000
Post-IPO equity
09 May
2014
$1,632,689
Venture capital
